Literature DB >> 24348127

Levetiracetam: more evidence of safety in pregnancy.

Mohamad Koubeissi.   

Abstract

Entities:  

Year:  2013        PMID： 24348127      PMCID： PMC3854744          DOI： 10.5698/1535-7597-13.6.279

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  9 in total

1.  Autism spectrum disorders following in utero exposure to antiepileptic drugs.

Authors:  R L Bromley; G Mawer; J Clayton-Smith; G A Baker
Journal:  Neurology       Date:  2008-12-02       Impact factor: 9.910

2.  Child development following in utero exposure: levetiracetam vs sodium valproate.

Authors:  R Shallcross; R L Bromley; B Irwin; L J Bonnett; J Morrow; G A Baker
Journal:  Neurology       Date:  2011-01-25       Impact factor: 9.910

3.  Comparative safety of antiepileptic drugs during pregnancy.

Authors:  S Hernández-Díaz; C R Smith; A Shen; R Mittendorf; W A Hauser; M Yerby; L B Holmes
Journal:  Neurology       Date:  2012-05-02       Impact factor: 9.910

4.  Lamotrigine and the risk of malformations in pregnancy.

Authors:  Marianne Cunnington; Patricia Tennis
Journal:  Neurology       Date:  2005-03-22       Impact factor: 9.910

5.  Newer-generation antiepileptic drugs and the risk of major birth defects.

Authors:  Ditte Mølgaard-Nielsen; Anders Hviid
Journal:  JAMA       Date:  2011-05-18       Impact factor: 56.272

6.  Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register.

Authors:  S Hunt; J Craig; A Russell; E Guthrie; L Parsons; I Robertson; R Waddell; B Irwin; P J Morrison; J Morrow
Journal:  Neurology       Date:  2006-11-28       Impact factor: 9.910

7.  Tolerability and efficacy of oral loading of levetiracetam.

Authors:  M Z Koubeissi; S Amina; I Pita; G K Bergey; M A Werz
Journal:  Neurology       Date:  2008-05-27       Impact factor: 9.910

8.  Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.

Authors:  Kimford J Meador; Gus A Baker; Nancy Browning; Jill Clayton-Smith; Deborah T Combs-Cantrell; Morris Cohen; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring
Journal:  N Engl J Med       Date:  2009-04-16       Impact factor: 91.245

9.  Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers.

Authors:  Ellen Mawhinney; John Craig; Jim Morrow; Aline Russell; W Henry Smithson; Linda Parsons; Patrick J Morrison; Brenda Liggan; Beth Irwin; Norman Delanty; Stephen J Hunt
Journal:  Neurology       Date:  2013-01-09       Impact factor: 9.910
  9 in total
  4 in total

1.  Monotherapy in newly diagnosed epilepsy: levetiracetam versus standard anticonvulsants.

Authors:  Mohamad Z Koubeissi
Journal:  Epilepsy Curr       Date:  2014-09       Impact factor: 7.500

Review 2.  Expert opinion: use of valproate in girls and women of childbearing potential with epilepsy: recommendations and alternatives based on a review of the literature and clinical experience-a European perspective.

Authors:  Manuel Toledo; Barbara Mostacci; Magdalena Bosak; Joanna Jedrzejzak; Rhys H Thomas; Javier Salas-Puig; Arnaud Biraben; Bettina Schmitz
Journal:  J Neurol       Date:  2020-04-01       Impact factor: 4.849

3.  Diagnostic and management challenges of intraventricular neurocysticercosis presenting in the third trimester of pregnancy: A case report.

Authors:  Devika Ramesh; Dilip K Maurya; Madhavan S Gopalakrishnan; Bhabani Pegu; Ramesh Ananthakrishnan; Pradeep P Nair; Anish Keepanasseril
Journal:  Obstet Med       Date:  2020-03-18

4.  Levetiracetam use during pregnancy in women with epilepsy: Preliminary observations from a tertiary care center in Northern India.

Authors:  Ramandeep Bansal; Vanita Suri; Seema Chopra; Neelam Aggarwal; Pooja Sikka; Subhas Chandra Saha; Manoj Kumar Goyal; Praveen Kumar
Journal:  Indian J Pharmacol       Date:  2018 Jan-Feb       Impact factor: 1.200
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.